DYEE Capital

Beluga Airlines is a large-scale unmanned cargo aircraft R&D and manufacturing company.

Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

Genepoint Biological Technology (China) Co., Ltd. specializes in the manufacture of devices for cryogenic biomaterial storage and handling, aimed at supporting life sciences research. Based in Shanghai, the company offers a range of products, including Automated Cryo-Bio Storage systems, Plugged Hybrid Cryo-Storage units, and LIN Vapor Freezers. These innovative solutions are designed to facilitate biotechnology research and development by enhancing the efficiency of sample storage operations. Genepoint is committed to advancing cryogenic robotic systems, enabling researchers to manage biological samples effectively and conduct experiments with greater ease.

Ininin is a technology service company in the packaging industry. They are creating digital business value in the packaging industry through the integration of cloud computing, big data, and machine intelligence integration of cloud computing, big data, and machine intelligence. They offer production and sales collaboration across the supply chain of paper packaging. They provide digital supply chain service solutions for the packaging industry, connecting various packaging factories, software and hardware manufacturers, and service providers in the industry through the packaging industry cloud.

Beijing Weilan New Energy Technology is an enterprise company focusing on the development and production of next-generation all-solid-state batteries. One of the battery companies with patents and technologies for all-solid-state battery cores. With the core concept of “Huijuwei Blue, Leading Solid State”, the company has a leading domestic and international leading technology and development team. The company was established in 2016 and is based in Beijing, China.

BridGene Biosciences is a biotechnology company focused on discovering and developing small molecules aimed at traditionally untreatable targets. The company employs advanced chemoproteomic technology, integrating covalent chemistry, chemical proteomics, and quantitative mass spectrometry to create highly selective small-molecule inhibitors. This innovative approach allows for proteome-wide screening in live cells, facilitating the identification of drug targets that have historically been considered undruggable. By leveraging these techniques, BridGene seeks to advance therapeutic development in the healthcare sector, ultimately contributing to the discovery of new drugs and improving treatment options.

Degron Therapeutics is a drug discovery platform focused on developing a new class of targeted protein degradation therapeutics, specifically small molecule molecular glue degrader drugs. The company aims to become a leader in the discovery and development of these innovative medicines, which target disease mechanisms that are often inaccessible to traditional small molecule inhibitors. By leveraging its advanced molecular glue protein degradation platform technology, Degron Therapeutics identifies and validates disease targets while creating novel selective compounds. This approach addresses significant unmet medical needs across various therapeutic areas. The company boasts a team of experienced executives and scientific leaders dedicated to enhancing treatment efficiency through its drug development initiatives.

Microclear is a developer and manufacturer of medical instruments focused on enhancing imaging services in ophthalmology and optometry. The company produces high-quality equipment, including a confocal retinal ophthalmoscope, a handheld fundus camera, a handheld slit lamp, and a vision screener. Utilizing artificial intelligence technology, Microclear's products aim to improve diagnostic accuracy for healthcare providers. Their offerings are distributed to hospitals and medical institutes worldwide, ensuring that practitioners have access to advanced imaging solutions for better patient care.

Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.

TenaFe, Inc. is a technology company that specializes in the development of solid-state drive (SSD) controllers aimed at enhancing data storage solutions across various platforms, including client devices, data centers, and emerging edge applications. Founded in 2018 and based in Campbell, California, TenaFe leverages its patented technology to deliver SSDs characterized by exceptional reliability, performance, and energy efficiency. These innovations serve a diverse array of devices, from connected gadgets and personal computers to large-scale data center operations, ultimately improving storage reliability and energy consumption for its clients.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative molecular pharmaceuticals and antibody drugs that target various cancer systems. GenFleet's work involves developing signal transduction regulators, tumor microenvironment modulators, and transcription factors, among other therapeutic agents. The company's mission is to provide effective medical solutions that can reactivate tumor-specific immune responses and enhance the body's own immune system in combating cancer. With a commitment to advancing cancer therapies, GenFleet serves both domestic and international markets.

Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.

Manteia Technology, founded in 2017 and based in Xiamen, China, specializes in radiology systems with a focus on cancer treatment. The company integrates deep learning and data technology to develop advanced solutions for tumor radiotherapy, including automatic target volume delineation software, dose calculation and evaluation systems, and intelligent adaptive radiotherapy systems. Manteia employs a skilled research and development team, comprised of approximately 50 engineers and algorithms, with a significant portion having medical backgrounds. The firm has garnered recognition as a "Double Hundred Talents" enterprise by the Xiamen Municipal Government and has received strategic investments from Fosun Group and Danlu Capital. Manteia holds 26 software copyrights, along with multiple patents, and its core personnel have published over 170 scientific papers in the field of radiotherapy. Additionally, the company has a wholly-owned subsidiary in the United States, further expanding its reach in the healthcare sector.

Zhimeng Biopharma, Inc. is a pharmaceutical company based in Shanghai, China, established in 2017. The company focuses on developing innovative treatments for chronic hepatitis B (CHB) and related liver diseases, with a pipeline that includes a HBV capsid inhibitor, HBsAg inhibitor, and various immunomodulators. In addition to its work on hepatitis B, Zhimeng is also advancing small molecule drugs aimed at treating neurological disorders, including epilepsy, pain, and strokes. The company's research targets multiple stages of the hepatitis B virus, with the goal of enhancing treatment options available to healthcare professionals and improving patient outcomes.

SinoTau is a comprehensive solution provider focused on both generic and innovative pharmaceuticals. The company specializes in the early development of antibody biopharmaceuticals and conducts research on a range of medications aimed at treating cancers, neurological disorders, and autoimmune diseases. With expertise in medicinal chemical synthesis, generic drug analysis, and pharmaceutical preparations, SinoTau supports the biotechnology industry through targeted drug development. Their work is underpinned by advanced diagnostic technologies and monoclonal antibody innovations, positioning them as a key player in the fields of cardiovascular health, neurodegeneration, and oncology.

Leads Biolabs is a biotechnology company focused on developing innovative antibody-based therapeutics to address unmet medical needs in oncology and immunological diseases. Founded in 2014 and headquartered in China, the company has established a strong research and development pipeline featuring over ten projects centered on monoclonal and bispecific antibodies for cancer immunotherapy. By concentrating on tumor immunotherapy, Leads Biolabs aims to enhance treatment outcomes and access for patients globally, thereby improving their medical conditions and overall quality of life.

Zenova Pharmaceutical specializes in the fields of research and development of new drugs, research, and development of high-end complex pharmaceutical preparations and specialty drugs.

Ionova Life Science Co., Ltd. is a biotechnology company based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. Founded in 2016, the company focuses on the discovery and development of novel medicines for cancer treatment, specializing in oncology, immuno-oncology, and tumor-targeted therapies. Ionova employs an in-house built discovery platform to facilitate the development of innovative anti-tumor drugs and immunomodulatory agents. Through its research efforts, the company aims to advance treatments that specifically target tumors and enhance the immune response against cancer.

Fabu Technology Limited, founded in 2017 and based in Hangzhou, China, specializes in providing software and hardware solutions for autonomous driving and related technologies. The company develops advanced systems that include autonomous driving solutions for cargo trucks, ranging from levels 2 to 4, as well as advanced driver assistance systems designed to enhance safety and efficiency in vehicles with significant blind spots. Fabu's technology leverages machine learning, computer vision, and robotics to support unmanned horizontal transportation systems in automated terminals. By integrating artificial intelligence, Fabu aims to streamline operations in the logistics and shipping industries, improving scheduling efficiency, reducing labor costs, and decreasing turnaround times in port operations.

Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. The company specializes in drug discovery and early development, primarily in the fields of immuno-oncology and eye diseases. Phanes Therapeutics is developing a range of therapeutic molecules, including a monoclonal antibody aimed at treating solid tumors, as well as therapies for age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, the company is working on bispecific antibodies targeting small cell lung cancer. Through its extensive scientific expertise and innovative approaches, Phanes Therapeutics aims to create effective treatment options that enhance patient care and improve outcomes for those suffering from various conditions.

Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.

SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.

FutureGen is a biopharmaceutical company focused on developing innovative biologics in the fields of immunology and cancer. The company utilizes its advanced Structure-based Targeted Evolution Platform (STEP) to efficiently screen and produce high-quality antibodies aimed at discovering new drug treatments. By integrating various technologies, FutureGen aims to enhance the development of antibody drugs that provide improved therapies for cancer and related diseases. The company possesses expertise in medication development, clinical research, and quality control, positioning it to make significant contributions to the biopharmaceutical industry and improve patient outcomes.

Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.

Maxi Novel specializes in the fields of oral combination of tumor immunity, targeted drugs, and chemotherapy drugs.

Innovision develops auxiliary diagnosis and treatment systems tailored for endoscopy centers in hospitals. The company utilizes artificial intelligence and deep learning technologies to enhance the medical imaging-assisted diagnosis of the digestive system. By processing digestive endoscopy image data, Innovision's systems aim to improve operational efficiency in hospitals, alleviating the workload of endoscopy doctors and minimizing the need for additional medical personnel. This approach supports healthcare providers in delivering better patient care while streamlining their clinical processes.

InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company specializes in targeted therapies, particularly for lung cancer, breast cancer, and gout. Its product pipeline includes small molecule drug candidates, such as D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in developing novel immuno-oncology therapies that can be used in conjunction with existing treatments like PD-1 antibodies for various cancer types. The company was co-founded by Dr. Yaolin Wang and other scientists with extensive experience in drug discovery at leading pharmaceutical firms, focusing on significant health challenges such as tumors and metabolic disorders.

KYEE is a manufacturer of products and services for the medical cloud business that covers many fields, such as medical cloud, smart ward, and big data in health care. The company's process of deepening medical information technology. KYEE helps medical institutions improve service quality and efficiency, ensuring medical safety effectively.

LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

Innovision develops auxiliary diagnosis and treatment systems tailored for endoscopy centers in hospitals. The company utilizes artificial intelligence and deep learning technologies to enhance the medical imaging-assisted diagnosis of the digestive system. By processing digestive endoscopy image data, Innovision's systems aim to improve operational efficiency in hospitals, alleviating the workload of endoscopy doctors and minimizing the need for additional medical personnel. This approach supports healthcare providers in delivering better patient care while streamlining their clinical processes.

Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Ionova Life Science Co., Ltd. is a biotechnology company based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. Founded in 2016, the company focuses on the discovery and development of novel medicines for cancer treatment, specializing in oncology, immuno-oncology, and tumor-targeted therapies. Ionova employs an in-house built discovery platform to facilitate the development of innovative anti-tumor drugs and immunomodulatory agents. Through its research efforts, the company aims to advance treatments that specifically target tumors and enhance the immune response against cancer.

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Allist Pharmaceuticals is a pharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, particularly in the area of cancer treatment. The company addresses unmet clinical needs within the global pharmaceutical market, emphasizing the importance of scientific and technological advancements to improve patient outcomes. Allist Pharmaceuticals is committed to creating safe and effective drugs that are backed by independent intellectual property rights, ensuring that their innovative therapies can meet the diverse needs of patients.

HeBaoDan is an S2B2C e-commerce platform that focuses on facilitating internet retail. It operates a new retail platform that aims to enhance the online shopping experience through community engagement. By promoting a business model that integrates social elements into the retail process, HeBaoDan seeks to create a more interactive and engaging environment for consumers. This approach not only streamlines the shopping experience but also fosters a sense of community among users, making it easier for them to connect and share their experiences.

ZongMu Technology, founded in January 2013 and headquartered in Shanghai's Pudong ZhangJiang high-tech park, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has established research and development centers in Beijing and Shenzhen. ZongMu is recognized as a leading provider of SurroundView ADAS solutions within the domestic Chinese automotive market, having successfully partnered with multiple original equipment manufacturers (OEMs) and their tier-one suppliers. Their product offerings include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems, all aimed at enhancing driving safety and assistance. Through innovative solutions and a commitment to service excellence, ZongMu continues to shape the future of automotive technology in China.

Weijiechengpei is a third-party logistics service provider based in urban areas, specializing in the distribution of goods for sectors such as catering, retail, and fresh e-commerce. Operating under the service brand Shanghai Kexin Logistics Co., Ltd., the company employs a model that combines consultation with logistics services. It focuses on B2B logistics management, particularly for restaurant and retail chains, and emphasizes logistics integration and the construction of B2B logistics networks. Weijiechengpei offers a range of services, including warehousing, distribution, packaging, and supply chain consulting, aimed at enhancing operational efficiency for its clients in the fast-moving consumer goods market and beyond.

FineEx is a prominent logistics service provider that focuses on e-commerce warehouse logistics and supply chain integration for brand owners and distributors. The company has established a nationwide logistics platform that combines warehousing and distribution services, leveraging a robust national warehousing network. By utilizing self-developed logistics systems and advanced technology, FineEx aims to enhance operational efficiency for both e-commerce and traditional retail businesses. Their services are designed to help enterprises reduce warehousing costs, improve turnover rates, and increase delivery efficiency, ultimately enhancing the overall customer experience.

Borns Robot Co., Ltd. is a manufacturer of surgical robots based in Chongqing, China, with an additional office in Chengdu. The company specializes in developing intelligent medical robotic devices designed for minimally invasive surgery, including porous laparoscopy robots. Borns Robot focuses on providing digital diagnosis and treatment solutions tailored for the needs of doctors and patients, addressing specific clinical requirements in the field of non-invasive surgical procedures.

KTVme is a digital entertainment platform that enhances the traditional television experience by offering a music ordering and entertainment service. It features a portal where users can select party songs and control set-top boxes, creating a karaoke-like environment tailored to individual preferences. This innovative approach allows users to enjoy music in a more personalized manner, transforming the way they engage with entertainment at home.

Xiamen SpaceGen Co., Ltd. specializes in the development, manufacturing, and retail of diagnostic and monitoring products aimed at cancer, genetic diseases, and personalized precision medical testing. Founded in 2015 and headquartered in Xiamen, China, the company offers a range of products, including diagnostic reagents, diagnostic kits, and mutation detection kits. SpaceGen has developed 32 clinical-grade detection kits specifically for lung cancer, breast cancer, and colon cancer, delivering high-quality precision medical solutions to healthcare professionals and patients. The company's focus on innovative services enhances the capabilities of individualized precision medical testing for tumors.

Huiyi Huiying is an international cloud computing, large data & AI tech that has created a digital medical imaging and tumor radiotherapy platform. It has also built a video intelligent screening system, leak detection system and the image Depth applied to the tumor, cardiovascular, acute abdomen and other single disease of artificial intelligence assisted diagnosis and treatment system.

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Xiao Qu Hao Hushi provides online medical consultancy services through an application.

ZongMu Technology, founded in January 2013 and headquartered in Shanghai's Pudong ZhangJiang high-tech park, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has established research and development centers in Beijing and Shenzhen. ZongMu is recognized as a leading provider of SurroundView ADAS solutions within the domestic Chinese automotive market, having successfully partnered with multiple original equipment manufacturers (OEMs) and their tier-one suppliers. Their product offerings include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems, all aimed at enhancing driving safety and assistance. Through innovative solutions and a commitment to service excellence, ZongMu continues to shape the future of automotive technology in China.

JDT focuses in providing technical products and solutions across the value chain for enterprises, governments and other customers.

Yidian Zixun is a mobile news aggregator founded in 2013 and headquartered in Beijing, China. The platform utilizes advanced search and recommendation technologies to deliver personalized content to its users. By analyzing user data, Yidian creates individual profiles that help define personal interests, allowing for the targeted distribution of news and media. The company employs professionals to generate content, rewarding those whose work effectively engages users and drives revenue. Additionally, Yidian develops a marketing database based on user interests, enhancing the precision of advertisement matching. Through its innovative approach, Yidian Zixun aims to provide a custom-tailored news experience that aligns with the unique preferences of each user.

Weijiechengpei is a third-party logistics service provider based in urban areas, specializing in the distribution of goods for sectors such as catering, retail, and fresh e-commerce. Operating under the service brand Shanghai Kexin Logistics Co., Ltd., the company employs a model that combines consultation with logistics services. It focuses on B2B logistics management, particularly for restaurant and retail chains, and emphasizes logistics integration and the construction of B2B logistics networks. Weijiechengpei offers a range of services, including warehousing, distribution, packaging, and supply chain consulting, aimed at enhancing operational efficiency for its clients in the fast-moving consumer goods market and beyond.

Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.